18F‐fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of clinically node‐negative non‐small cell lung cancer

One in four non‐small cell lung cancer (NSCLC) patients are diagnosed at an early‐stage. Following the results of the National Lung Screening Trial that demonstrated a survival benefit for low‐dose computed tomography screening in high‐risk patients, the incidence of early‐stage NSCLC is expected to...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Yusuke, Suzuki, Shigeki, Matsutani, Noriyuki, Kawamura, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Mini Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397908/
https://www.ncbi.nlm.nih.gov/pubmed/30666803
http://dx.doi.org/10.1111/1759-7714.12978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397908/
https://www.ncbi.nlm.nih.gov/pubmed/30666803
http://dx.doi.org/10.1111/1759-7714.12978

Ejemplares similares